ACHCACHCHealthcare · Medical Care Facilities

ACHC Stock Forecast: Acadia Healthcare Co., Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$31
+1.95% on the day

The 14 Wall Street analysts covering Acadia Healthcare Co., Inc. hold a median 12-month price target of $32 — +3.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 54 of 100 as at 13 Aug 2026 — in the upper half.

Market cap
$2.9B
Ticker Nerd rank
54 / 100
Median analyst target
$32
Analysts covering
14
Total return, dividends reinvested
1W
−2.2%
1M
−2.4%
YTD
+117.3%
1Y
+49.2%
From 52W high
−13.4%
From 52W low
+164.0%
$12
$36
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ACHC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Acadia Healthcare Co., Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 13 Aug 2026
54 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
92
Revisions
85
Momentum
65
Value
59
Issuance
42
Size
32
Growth
30
Volatility
27
Quality
18

Accruals (92): Reported profit is backed by cash, and the company is not expanding recklessly.

Quality (18): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ACHC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ACHC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$20$30$40Oct 25Jan 26Apr 26Jul 26ACHCHigh $41Median $32Low $15

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says14 analysts
8 Buy5 Hold1 Sell
Low $15Median $32High $41

The green dot is the last close — the median target sits +3.8% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 6 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
30 July 2026BarclaysMaintainsEqual-Weight$25$32
30 July 2026GuggenheimMaintainsBuy$38$39
20 July 2026GuggenheimMaintainsBuy
20 July 2026GuggenheimMaintainsBuy$31$38
14 July 2026KeybancMaintainsOverweight$30$40
14 July 2026KeybancMaintainsOverweight
14 July 2026TD CowenMaintainsBuy$30$36
14 July 2026TD CowenMaintainsBuy
9 July 2026UBSMaintainsBuy$31$39
9 July 2026UBSMaintainsBuy
3 June 2026JefferiesUpgradeBuy
4 May 2026GuggenheimMaintainsBuy
4 May 2026RBC CapitalMaintainsOutperform
1 May 2026BarclaysMaintainsEqual-Weight
1 May 2026Cantor FitzgeraldMaintainsNeutral
28 Apr 2026TD CowenMaintainsBuy
17 Apr 2026UBSMaintainsBuy
3 Mar 2026BarclaysMaintainsEqual-Weight
26 Feb 2026Leerink PartnersMaintainsMarket Perform
26 Feb 2026RBC CapitalMaintainsOutperform

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ACHC appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

ACHC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+3.8%
Analysts raising
2
Analysts cutting
1
Fundamentals

Acadia Healthcare Co., Inc. (ACHC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
20.6×

Cheaper than 38% of US stocks

Price / sales
0.9×

Cheaper than 74% of US stocks

Price / book
1.4×

Cheaper than 59% of US stocks

EV / EBITDA
10.2×

Cheaper than 38% of US stocks

Growth & margins
Revenue growth (YoY)
−0.4%

Higher than 27% of US stocks

Earnings growth (YoY)
−63.7%

Higher than 7% of US stocks

Gross margin
96.5%

Higher than 99% of US stocks

Operating margin
10.1%

Higher than 64% of US stocks

Net margin
−33.4%

Higher than 13% of US stocks

Returns & dividend
Return on equity
−41.4%

Higher than 23% of US stocks

Return on assets
3.6%

Higher than 69% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

ACHC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
ACHCAcadia Healthcare Co., Inc.$2.9B
54
BKDBrookdale Senior Living, Inc.$3.0B
76
AVAHAveanna Healthcare Holdings, Inc.$2.5B
90
GRDNGuardian Pharmacy Services, Inc.$2.4B
80
NHCNational HealthCare Corp.$3.4B
68
ADUSAddus HomeCare Corp.$2.2B
95
MDPediatrix Medical Group, Inc.$2.2B
99

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Acadia Healthcare Co., Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ACHC news & analysis

Should You Continue to Hold ACHC Stock at an 18.17X P/E Valuation?

Zacks Investment Research · 14 Aug 2026neutral

Zacks reports that Acadia Healthcare's premium valuation (18.17x P/E) faces a key test, with facility growth and stronger EBITDA guidance balanced against rising costs and weaker returns. The article weighs these competing factors for ACHC's outlook.

Why it matters — ACHC watchers would care because the piece highlights the tension between the company's growth and earnings guidance and the cost pressures and weaker returns that could affect its premium valuation.

Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire · 12 Aug 2026negative

A law firm has issued a notice indicating that Acadia Healthcare insiders may have breached their fiduciary duties to shareholders, encouraging shareholders to contact the firm to discuss their rights and legal options. The firm states it would handle any matter on a contingent fee basis with no out-of-pocket costs.

Why it matters — ACHC watchers would care because this signals a potential securities-related legal action or investigation concerning the company's insiders and their fiduciary conduct.

Acadia Healthcare Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC

Business Wire · 10 Aug 2026negative

Law firm Kahn Swick & Foti continues its investigation into Acadia Healthcare's officers and directors, following the company's September 2024 disclosure that it received a voluntary information request from the U.S. Attorney's Office and a grand jury subpoena.

Why it matters — The ongoing investigation and federal subpoenas raise legal and regulatory concerns for Acadia Healthcare that investors should monitor.

Robbins LLP Notifies Acadia Healthcare (ACHC) Investors that the Lawsuit Survived Defendants' Motion to Dismiss - Contact Robbins LLP for Information

PRNewsWire · 31 July 2026negative

A securities lawsuit against Acadia Healthcare has survived the defendants' motion to dismiss, allowing the case to proceed in court. Robbins LLP is reminding investors of their rights regarding the ongoing litigation.

Why it matters — ACHC watchers should note that the securities claims against the company are moving forward after the court denied the motion to dismiss, which could lead to further legal and financial repercussions.

Acadia Healthcare Company, Inc. (ACHC) Q2 2026 Earnings Call Transcript

Seeking Alpha · 30 July 2026neutral

Acadia Healthcare held its Q2 2026 earnings call, and a transcript of the event was published by Seeking Alpha. The call covered the company's financial results and operational performance for the quarter.

Why it matters — The earnings call transcript provides investors and analysts with detailed commentary from management on Acadia's quarterly performance, strategy, and outlook.

FAQ

Frequently asked questions about ACHC stock

What is the ACHC stock price forecast for 2026-2027?

The 14 Wall Street analysts covering Acadia Healthcare Co., Inc. have a median 12-month price target of $32, with estimates ranging from $15 to $41. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ACHC stock a buy right now?

Of the 14 analysts covering Acadia Healthcare Co., Inc., 8 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Acadia Healthcare Co., Inc. 54 out of 100 across roughly 4,600 US stocks as at 13 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ACHC?

As at 13 Aug 2026, Acadia Healthcare Co., Inc. ranks 54 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (92 of 100).

Will ACHC stock go up?

No one can know that. What the data says: the median 12-month target from 14 analysts implies +3.8% from the last close, and Ticker Nerd's factor model ranks Acadia Healthcare Co., Inc. 54 out of 100 as at 13 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ACHC stock forecast for 2030?

No analyst covering Acadia Healthcare Co., Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ACHC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $15 to $41 over the next 12 months.

How has ACHC stock performed over the past year?

Acadia Healthcare Co., Inc. returned +49.2% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Acadia Healthcare Co., Inc. do?

Acadia Healthcare Company, Inc. is a U.S.-based provider of behavioral healthcare services, headquartered in Franklin, Tennessee.

What is the latest news on ACHC?

The most recent item we track (Zacks Investment Research, 14 Aug 2026): "Should You Continue to Hold ACHC Stock at an 18.17X P/E Valuation?". Zacks reports that Acadia Healthcare's premium valuation (18.17x P/E) faces a key test, with facility growth and stronger EBITDA guidance balanced against rising costs and weaker returns. The article weighs these competing factors for ACHC's outlook.

Company

About Acadia Healthcare Co., Inc.

Acadia Healthcare Company, Inc. is a U.S.-based provider of behavioral healthcare services, headquartered in Franklin, Tennessee. The company operates a large network of treatment facilities across numerous states and Puerto Rico, focusing on mental health and substance use disorders. Its portfolio includes inpatient psychiatric hospitals, specialty treatment centers, residential treatment facilities, outpatient clinics, and comprehensive treatment centers for opioid use disorder. Acadia Healthcare serves children, adolescents, adults, and seniors, offering multiple levels of care that range from acute crisis stabilization to longer-term therapeutic programs. The company generates revenue primarily from inpatient psychiatric and substance abuse services, outpatient behavioral health programs, and adolescent residential treatment. Within the healthcare sector, Acadia Healthcare plays a significant role in expanding access to behavioral health services, particularly in specialized and acute care settings, and is recognized as one of the larger dedicated behavioral health systems in the United States.

CEO Ms. Debra K. Osteen · 25,000 employees · United States · https://www.acadiahealthcare.com